Etipirium

Etipirium

SCHEMBL29388403

C[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCC1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 11/20 0.69
CHRM3 P20309 10/20 0.69
CHRM1 P11229 5/20 0.69
CYP2D6 P10635 3/20 0.69
CHRM4 P08173 3/20 0.69
CHRM5 P08912 2/20 0.69
ALDH1A1 P00352 3/20 0.59
KDM4E B2RXH2 1/20 0.59
CTDSP1 Q9GZU7 1/20 0.59
LMNA P02545 2/20 0.54
KCNH2 Q12809 2/20 0.54
HRH1 P35367 1/20 0.54
APOBEC3A P31941 1/20 0.53
HTT P42858 1/20 0.53
APOBEC3G Q9HC16 1/20 0.53
RAB9A P51151 1/20 0.53
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
POLB P06746 1/20 0.52
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Etipirium SCHEMBL916033 0.99 CHRM2 (0.67) CHRM2CHRM3CHRM1CYP2D6CHRM4
Dimetipirium SCHEMBL29387697 0.78 CHRM2 (0.56) CHRM2CHRM3CHRM1CYP2D6CHRM4
Dimetipirium SCHEMBL2733698 0.77 CHRM2 (0.58) CHRM2CHRM3CHRM1CYP2D6CHRM4
SCHEMBL5158545 0.76 MEN1 (0.68) CHRM2CHRM3CHRM1CYP2D6CHRM4
Bevonium SCHEMBL1650540 0.74 CHRM2 (0.51) CHRM2CHRM3CHRM1CYP2D6CHRM4
SCHEMBL29925238 0.74 CHRM3 (0.60) CHRM2CHRM3CHRM1CYP2D6CHRM4
SCHEMBL5161453 0.73 MEN1 (0.64) CHRM2CHRM3CHRM1CYP2D6CHRM4
Poldine SCHEMBL1641786 0.72 CHRM2 (0.55) CHRM2CHRM3CHRM1CYP2D6CHRM4
Bromide SCHEMBL1872736 0.72 CHRM3 (0.62) CHRM2CHRM3CHRM1CYP2D6LMNA
Bromide SCHEMBL1872734 0.72 CHRM3 (0.62) CHRM2CHRM3CHRM1CYP2D6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220047505-A1 Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration STI PHARMA, LLC (US) 2022-02-17 US disclosed